Pablo G. Legorreta - Insider Trading & Ownership

Location
110 E 59 Th Street, Suite 3300, New York, NY
Summary
The estimated net worth of Pablo G. Legorreta is at least $2.98B dollars as of November 7, 2025. Pablo G. Legorreta is the CEO, Chairman of the Board, Director of Royalty Pharma plc and owns shares of Royalty Pharma plc (RPRX) stock worth about $2.59B. Pablo G. Legorreta is the Director, 10%+ Owner of PROKIDNEY CORP. and owns shares of PROKIDNEY CORP. (PROK) stock worth about $396M. Pablo G. Legorreta is the Director, 10%+ Owner of Epizyme, Inc. and owns shares of Epizyme, Inc. stock worth about $23K.
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for Pablo G. Legorreta
All Insider Reports
All Insider Reports

Notify me when Pablo G. Legorreta files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Pablo G. Legorreta

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RPRX Royalty Pharma plc CEO, Chairman of the Board, Director $2.59B Nov 5, 2025
PROK PROKIDNEY CORP. Director, 10%+ Owner $396M Jun 3, 2025
EPZM Epizyme, Inc. Director, 10%+ Owner $23K Aug 12, 2022

Insider Transactions Reported by Pablo G. Legorreta:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.